These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


658 related items for PubMed ID: 7515621

  • 1. Effects of the potassium channel openers cromakalim and pinacidil on catecholamine secretion and calcium mobilization in cultured bovine adrenal chromaffin cells.
    Masuda Y, Yoshizumi M, Ishimura Y, Katoh I, Oka M.
    Biochem Pharmacol; 1994 May 18; 47(10):1751-8. PubMed ID: 7515621
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-induced catecholamine release and intracellular Ca2+ increase via suppression of K+ channels in cultured rat adrenal chromaffin cells.
    Mochizuki-Oda N, Takeuchi Y, Matsumura K, Oosawa Y, Watanabe Y.
    J Neurochem; 1997 Jul 18; 69(1):377-87. PubMed ID: 9202332
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory mechanism of pinacidil on catecholamine secretion from the rat perfused adrenal gland evoked by cholinergic stimulation and membrane depolarization.
    Lim DY, Park GH, Park SH.
    J Auton Pharmacol; 2000 Apr 18; 20(2):123-32. PubMed ID: 11095550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CCCP enhances catecholamine release from the perfused rat adrenal medulla.
    Lim DY, Park HG, Miwa S.
    Auton Neurosci; 2006 Jul 30; 128(1-2):37-47. PubMed ID: 16461015
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Large- and small-conductance Ca(2+)-activated K+ channels: their role in the nicotinic receptor-mediated catecholamine secretion in bovine adrenal medulla.
    Wada A, Urabe M, Yuhi T, Yamamoto R, Yanagita T, Niina H, Kobayashi H.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov 30; 352(5):545-9. PubMed ID: 8751084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents.
    Lückhoff A, Busse R.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul 30; 342(1):94-9. PubMed ID: 1698266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
    Fabiani ME, Vlahos R, Story DF.
    Pharmacol Res; 1996 Jul 30; 33(4-5):261-72. PubMed ID: 8938019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of intracellular calcium by potassium channel openers in vascular muscle.
    Erne P, Hermsmeyer K.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec 30; 344(6):706-15. PubMed ID: 1775202
    [Abstract] [Full Text] [Related]

  • 18. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H.
    J Cardiovasc Pharmacol; 1993 Dec 30; 22(6):863-8. PubMed ID: 7509906
    [Abstract] [Full Text] [Related]

  • 19. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H, Kitagaki K, Goto S, Suda H, Koda A.
    Jpn J Pharmacol; 1991 May 30; 56(1):13-21. PubMed ID: 1831870
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T, Nakajima S, Izawa T, Fukushima H, Nishikori K.
    Eur J Pharmacol; 1991 Apr 10; 196(1):1-7. PubMed ID: 1678711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.